Abstract
Ethinyloestradiol is the oestrogen most often present in combined oral contraceptive steroid preparations. We have shown that this steroid has a mean bioavailability of only 40%1owing to extensive first-pass metabolism. A large proportion of this first-pass metabolism occurs in the gut wall during absorption with the formation of a sulphate conjugate.2 Sulphate conjugation of other drugs such as paracetamol is inhibited by ascorbic acid,3 a drug that also undergoes sulphate conjugation in the gut wall. In a preliminary study four out of six women showed an increase in plasma ethinyloestradiol concentrations when a single dose of ethinyloestradiol was administered with ascorbic acid.4 We therefore studied the effect of ascorbic acid in women receiving long-term treatment with oral contraceptive steroids. © 1981, British Medical Journal Publishing Group. All rights reserved.
Cite
CITATION STYLE
Back, D. J., Breckenridge, A. M., MacIver, M., L’E Orme, M., Purba, H., & Rowe, P. H. (1981). Interaction of ethinyloestradiol with ascorbic acid in man. British Medical Journal (Clinical Research Ed.), 282(6275), 1516. https://doi.org/10.1136/bmj.282.6275.1516
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.